Skip to main content
SpringerLink
Log in

Genomic profiling is a supplemental diagnostic and therapeutic modality for hairy cell leukemia variant

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Shao H, Calvo KR, Gronborg M et al (2013) Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria. Leuk Res 37:401–409

    Article  CAS  Google Scholar 

  2. Robak T, Blasinska-Morawiec M, Blonski J et al (1999) 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland. Eur J Haematol 62:49–56

    Article  CAS  Google Scholar 

  3. Catovsky D, O’Brien M, Melo JV et al (1984) Hairy cell leukemia (HCL) variant: an intermediate disease between HCL and B prolymphocytic leukemia. Semin Oncol 11:362–369

    CAS  PubMed  Google Scholar 

  4. Visentin A, Imbergamo S, Trimarco V, Pravato S, Romano Gargarella L, Frezzato F, Scapinello G, Bertorelle R, Piva E, Facco M, Semenzato G, Piazza F, Trentin L (2020) Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literature. Hematol Oncol 38:823–826

    Article  CAS  Google Scholar 

  5. Robak T (2006) Current treatment options in hairy cell leukemia and hairy cell leukemia variant. Cancer Treat Rev 32:365–376

    Article  CAS  Google Scholar 

  6. Tiacci E, Pettirossi V, Schiavoni G, Falini B (2017) Genomics of Hairy Cell Leukemia. J Clin Oncol 35:1002–1010

    Article  CAS  Google Scholar 

  7. Durham BH, Getta B, Dietrich S, Taylor J, Won H, Bogenberger JM, Scott S, Kim E, Chung YR, Chung SS, Hüllein J, Walther T, Wang L, Lu SX, Oakes CC, Tibes R, Haferlach T, Taylor BS, Tallman MS, Berger MF, Park JH, Zenz T, Abdel-Wahab O (2017) Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations. Blood 130:1644–1648

    Article  CAS  Google Scholar 

  8. Zhang R, Wu Y, Wang X, Lu X, Li Y, Li S, Yan X (2020) Difference of genomic copy numbers alterations between hairy cell leukemia-variant and classical hairy cell leukemia: a pilot retrospective study in Chinese. Int J Med Sci 17:325–331

    Article  CAS  Google Scholar 

  9. Hwang Y, Lee JY, Mun YC et al (2011) Various patterns of IgH deletion identified by FISH using combined IgH and IgH/CCND1 probes in multiple myeloma and chronic lymphocytic leukemia. Int J Lab Hematol 33:299–304

    Article  CAS  Google Scholar 

  10. Bohn JP, Wanner D, Steurer M (2017) Ibrutinib for relapsed refractory hairy cell leukemia variant. Leuk Lymphoma 58:1224–1226

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Oklahoma Health Sciences Center, Stephenson Cancer Center, 800 NE 10th street, Oklahoma City, OK, 73104, USA

    Amany R. Keruakous, Pragathi Balakrishna, Sarah A. Schmidt, Marcus T. Autry & Adam Asch

Authors
  1. Amany R. Keruakous
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pragathi Balakrishna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sarah A. Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marcus T. Autry
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Adam Asch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amany R. Keruakous.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Study Objectives

• Demonstrate a successful example for the management of vHCL

• Generate a hypothesis to change the platform for the management of vHCL into a personalized approach based on genomic profiling.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Keruakous, A.R., Balakrishna, P., Schmidt, S.A. et al. Genomic profiling is a supplemental diagnostic and therapeutic modality for hairy cell leukemia variant. Ann Hematol 100, 1629–1630 (2021). https://doi.org/10.1007/s00277-021-04408-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-021-04408-z

Search

Navigation